Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
abbvie
astrazeneca
biogen
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
springworks therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
89bio
What
bio
3
×
biotech
3
×
drug
roundup
alzheimer’s
analysis
annual
assessed
attention
august
bring
busy
communities
company
conference
days
decisions
develop
devices
diseases
drugs
employing
esmo
europe
fda
genetic
germany
goldfinch
hosted
investment
ipo
kidney
later
lead
legacy
medicines
million
munich
new
news
Language
unset
Current search:
biotech
×
bio
×
biotech
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
